Smith+Nephew announced results for its CARTIHEAL AGILI-C Cartilage Repair Implant from a recent multicentre randomized controlled trial (RCT) treating knee cartilage defects. When compared to the current surgical standard of care (debridement or microfracture), findings demonstrated:
Patients treated with the CARTIHEAL AGILI-C Implant reported significantly better knee pain relief, and quality of life improvements over a four-year period.
Patients treated with the CARTIHEAL Implant reported superior improvements in performing activities related to daily living, sport and recreation at two and four years.
The scaffold effectively treated a broad group of patients across age, lesion size and presence of osteoarthritis while delivering clinically meaningful results.
Dr. Vinod Dasa of Louisiana State University School of Medicine finds the technology particularly meaningful for his patients. “The patients that come to see me are looking for a bridging procedure that enables them to continue their day-to-day life, playing with their kids and grandkids. In addition to the pain relief and functional gains, the 87% reduction in the risk of subsequent total knee arthroplasty (TKA) and osteotomy compared to the surgical standard of care resonates with almost every patient. The potential to delay if not avoid TKA is top of mind of almost every patient with mild/moderate osteoarthritis.”
Smith+Nephew announced results for its CARTIHEAL AGILI-C Cartilage Repair Implant from a recent multicentre randomized controlled trial (RCT) treating knee cartilage defects. When compared to the current surgical standard of care (debridement or microfracture), findings demonstrated:
Patients treated with the CARTIHEAL AGILI-C Implant...
Smith+Nephew announced results for its CARTIHEAL AGILI-C Cartilage Repair Implant from a recent multicentre randomized controlled trial (RCT) treating knee cartilage defects. When compared to the current surgical standard of care (debridement or microfracture), findings demonstrated:
Patients treated with the CARTIHEAL AGILI-C Implant reported significantly better knee pain relief, and quality of life improvements over a four-year period.
Patients treated with the CARTIHEAL Implant reported superior improvements in performing activities related to daily living, sport and recreation at two and four years.
The scaffold effectively treated a broad group of patients across age, lesion size and presence of osteoarthritis while delivering clinically meaningful results.
Dr. Vinod Dasa of Louisiana State University School of Medicine finds the technology particularly meaningful for his patients. “The patients that come to see me are looking for a bridging procedure that enables them to continue their day-to-day life, playing with their kids and grandkids. In addition to the pain relief and functional gains, the 87% reduction in the risk of subsequent total knee arthroplasty (TKA) and osteotomy compared to the surgical standard of care resonates with almost every patient. The potential to delay if not avoid TKA is top of mind of almost every patient with mild/moderate osteoarthritis.”
Copy to clipboard 
